| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Apr―14 |
Editorial: Pandemic preparedness in vaccine safety and regulation |
Manal M. Younus, Florence van Hunsel |
| 2 |
[GO] |
2025―Dec―29 |
Cohort event monitoring of booster COVID-19 vaccine safety using patient-reported outcomes in pregnant women |
Emeline Maisonneuve, Nicoletta Luxi, Chiara Bellitto, Francesco Ciccimarra, Monika Raethke, Florence van Hunsel, et al. (+18) Thomas Lieber, Erik Mulder, Fabio Riefolo, Felipe Villalobos, Nicolas H. Thurin, Francisco Batel-Marques, Kathryn Morton, Fergal O'Shaughnessy, Brian Cleary, Simona Sonderlichová, Andreea Farcas, Camelia Bucsa, Guillaume Favre, Satu J. Siiskonen, David Baud, Miriam C. J. M. Sturkenboom, Gianluca Trifirò, Alice Panchaud |
| 3 |
[GO] |
2025―Dec―01 |
The use of observed-to-expected analyses as a signal detection tool in COVID-19 vaccine safety surveillance: lessons learned from an industry perspective |
Laurence Serradell, Antonella Fretta, Jenny Nachbar, Jill Dreyfus, Diana Garofalo, Arianna Lucini, et al. (+5) Susan Mather, Daina Esposito, Anne-Laure Chabanon, Vincent Bauchau, Sarah Sellers |
| 4 |
[GO] |
2025―Dec―01 |
Background incidence rates from electronic healthcare databases for vaccine safety monitoring: review of challenges from the COVID-19 vaccination campaign and proposal for best practices |
Sonja Gandhi-Banga, Laurence Serradell, Deborah Layton, Jill Dreyfus, Nicolas Praet, Diana C. Garofalo, et al. (+3) Vincent Bauchau, Scott P. Kelly, Lin Li |
| 5 |
[GO] |
2025―Nov―25 |
The role of MedDRA in global pharmacovigilance and public health during COVID-19: pandemic preparedness and response |
Brian O’Hare, Heba Ibrahim, Patrick Revelle |
| 6 |
[GO] |
2025―Nov―14 |
Reporting rates of abnormal uterine bleeding after COVID-19 vaccination in South Korea |
Jae Min Lee, Seung Geun Yeo, Sung Soo Kim, Dong Choon Park |
| 7 |
[GO] |
2025―Aug―15 |
A national pharmacovigilance centre perspective on pandemic preparedness - lessons learned from the COVID-19 pandemic |
Florence van Hunsel, Agnes Kant |
| 8 |
[GO] |
2024―Aug―12 |
Cohort event monitoring of safety of COVID-19 vaccines: the Italian experience of the “ilmiovaccinoCOVID19 collaborating group” |
Nicoletta Luxi, Chiara Bellitto, Francesco Ciccimarra, Emiliano Cappello, Luca L’Abbate, Marco Bonaso, et al. (+27) Chiara Ajolfi, Paolo Baldo, Roberto Bonaiuti, Claudio Costantino, Giovambattista De Sarro, Cristina Di Mauro, Giuseppina Fava, Marina Ferri, Alberto Firenze, Fabiana Furci, Luca Gallelli, Luca Leonardi, Giovanna Negri, Fabio Pieraccini, Elisabetta Poluzzi, Chiara Sacripanti, Elisa Sangiorgi, Ester Sapigni, Ilenia Senesi, Roberto Tessari, Luigia Trabace, Alfredo Vannacci, Francesca Venturini, Francesco Vitale, Donatella Zodda, Marco Tuccori, Gianluca Trifirò |
| 9 |
[GO] |
2024―Jan―31 |
Menstrual disorders following COVID-19 vaccination: a review using a systematic search |
Veerle R. Smaardijk, Rana Jajou, Agnes Kant, Florence P. A. M. van Hunsel |
| 10 |
[GO] |
2023―Aug―25 |
The risk of preterm labor after COVID-19 vaccination before and during pregnancy |
M. de Feijter, L. C. M. Vissers, L. Davidson, A. C. Kant, P. J. Woestenberg |
| 11 |
[GO] |
2022―Oct―26 |
Establishing patient safety monitoring in the benefit-risk paradigm for off-label and emergency use of medications for COVID-19: A pharmacovigilance perspective |
Marina A. Malikova, Gianluca Trifirò, Giorgio Racagni, Dennis Van Liew, Peggy Webster, Tejal S. Brahmbhatt |
|
